<div id="readability-page-1"><p>Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 884 shares of the stock in a transaction on Monday, December 29th. The stock was sold at an average price of $38.01, for a total transaction of $33,600.84. Following the sale, the chief executive officer directly owned 35,835 shares in the company, valued at $1,362,088.35. This trade represents a 2.41% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.</p><div><p><span></span><span>Get <strong>Kewaunee Scientific</strong> alerts:</span></p></div><ul><li>3 Hot Micro-Caps On EPS Watch</li></ul><p>Thomas David Hull III also recently made the following trade(s): </p><ul><li>On Monday, December 22nd, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $39.00, for a total transaction of $39,000.00. </li></ul><h2>Kewaunee Scientific Price Performance</h2><p>Shares of NASDAQ:KEQU traded up $0.65 during trading on Wednesday, reaching $38.06. 1,738 shares of the company's stock traded hands, compared to its average volume of 15,584. The company has a quick ratio of 1.71, a current ratio of 2.48 and a debt-to-equity ratio of 0.81. Kewaunee Scientific Corporation has a fifty-two week low of $30.33 and a fifty-two week high of $71.33. The company has a 50-day simple moving average of $39.92 and a 200-day simple moving average of $46.99. The firm has a market cap of $109.23 million, a PE ratio of 9.66 and a beta of 0.61. </p><p>Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last issued its quarterly earnings data on Wednesday, December 10th. The technology company reported $0.91 EPS for the quarter. The company had revenue of $70.10 million for the quarter. Kewaunee Scientific had a return on equity of 22.39% and a net margin of 4.11%.During the same period in the previous year, the business posted $1.01 earnings per share. </p><h2>Analyst Ratings Changes</h2><p>Several equities analysts have issued reports on the stock. Weiss Ratings  reaffirmed a &#34;hold (c+)&#34; rating on shares of Kewaunee Scientific in a report on Wednesday, October 8th. Wall Street Zen downgraded shares of Kewaunee Scientific from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research report on Saturday, December 13th. One analyst  has rated the stock with a Hold rating,  According to MarketBeat, Kewaunee Scientific presently has an average rating of &#34;Hold&#34;.</p><p><b>Read Our Latest Stock Analysis on Kewaunee Scientific</b></p><h2>Institutional Inflows and Outflows</h2><p>Institutional investors have recently bought and sold shares of the business. Bank of America Corp DE grew its position in shares of  Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock valued at $28,000 after purchasing an additional 443 shares in the last quarter.  Annis Gardner Whiting Capital Advisors LLC purchased a new stake in  Kewaunee Scientific in the 3rd quarter valued at $38,000.  US Bancorp DE increased its stake in shares of  Kewaunee Scientific by 80.0% in the 3rd quarter. US Bancorp DE now owns 900 shares of the technology company's stock worth $38,000 after acquiring an additional 400 shares during the last quarter.  Raymond James Financial Inc. acquired a new stake in shares of  Kewaunee Scientific in the 2nd quarter worth $60,000.  Finally, Wedbush Securities Inc. purchased a new position in shares of  Kewaunee Scientific during the 2nd quarter worth $232,000. 32.69% of the stock is owned by hedge funds and other institutional investors. </p><h2>Kewaunee Scientific Company Profile</h2> (Get Free Report)<p>Kewaunee Scientific Corporation <span>NASDAQ: KEQU<span></span></span> is a global designer and manufacturer of scientific laboratory furniture, casework, fume hoods, containment solutions and related equipment. With roots dating back more than a century, the company develops integrated lab environments for research facilities, universities, biopharma companies, healthcare providers and government laboratories. Its product portfolio encompasses modular and custom casework, workstations, shelving systems, steel and epoxy resin solutions, as well as advanced ventilation and water management systems.  </p><p>The company operates primary manufacturing facilities in Fitchburg, Wisconsin, supported by regional distribution and service centers in North America, Europe and Asia.</p><h2>Recommended Stories</h2><ul><li>Five stocks we like better than Kewaunee Scientific</li><li>Do not delete, read immediately</li><li>ALERT: Drop these 5 stocks before January 2026!</li><li>The Crash Has Already Started (Most Just Don’t See It Yet)</li><li>[No Brainer Gold Play]: “Show me a better investment.”</li><li>INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S0VRVQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9S0VRVQ"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Kewaunee Scientific Right Now?</h2><p>Before you consider Kewaunee Scientific, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.</p><p>While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

KEQU

<p>Kewaunee Scientific CEO Thomas David Hull III sold 884 shares of the company's stock for $33,600.84 at an average price of $38.01 on December 29th. This sale reduced his ownership by 2.41%, leaving him with 35,835 shares valued at $1,362,088.35. The transaction was disclosed in a SEC filing. Hull also sold 1,000 shares on December 22nd for $39,000. Kewaunee's stock traded at $38.06, with a market cap of $109.23 million and a PE ratio of 9.66. Analysts currently rate the stock as a "Hold."</p>

Kewaunee Scientific (NASDAQ:KEQU) CEO Sells $33,600.84 in Stock